 | Form 4 Filings | Insider Buys | Significant Buys | Penny Stocks Insider Buying | Insider Sales |
| Insider Buy Sell Ratios | Stock Options | Insider Trading Stock Screener | Insider Trading Graph View | Insider Watch |
Insider Trading - Aligos Therapeutics Inc. (ALGS)
| | "Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise" - Peter Lynch What is insider trading>> SPAC List: List of Special Purpose Acquisition Companies |
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2020-10-20 Purchase | 2020-10-20 4:58 pm | Aligos Therapeutics Inc. | ALGS | Versant Venture Capital VI L.P. Versant Vantage I L.P. 10% Owner | 200,000 | $15 | $3,000,000 | 862,444 (Indirect Direct) | View |
| 2020-10-20 Purchase | 2020-10-20 4:59 pm | Aligos Therapeutics Inc. | ALGS | Vivo Capital VIII LLC Vivo Capital Fund VIII L.P. Vivo Capital Surplus Fund VIII L.P. 10% Owner | 550,000 | $15 | $8,250,000 | 430,372 (Indirect) | View |
| 2020-10-20 Purchase | 2020-10-20 5:00 pm | Aligos Therapeutics Inc. | ALGS | Woiwode Thomas Director | 200,000 | $15 | $3,000,000 | 862,444 (Indirect) | View |
| 2020-10-20 Purchase | 2020-10-22 4:31 pm | Aligos Therapeutics Inc. | ALGS | Novo Holdings A/S 10% Owner | 200,000 | $15 | $3,000,000 | 2,614,563 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2020-10-20 Conversion | 2020-10-20 4:53 pm | N/A N/A | Aligos Therapeutics Inc. | ALGS | Beigelman Leonid President | 163,842 | $0 | 163,842 (Indirect) | View |
| 2020-10-20 Conversion | 2020-10-20 4:53 pm | N/A N/A | Aligos Therapeutics Inc. | ALGS | Beigelman Leonid President | 13,559 | $0 | 13,559 (Indirect) | View |
| 2020-10-20 Conversion | 2020-10-20 4:53 pm | N/A N/A | Aligos Therapeutics Inc. | ALGS | Beigelman Leonid President | 13,559 | $0 | 13,559 (Indirect) | View |
| 2020-10-20 Conversion | 2020-10-20 4:53 pm | N/A N/A | Aligos Therapeutics Inc. | ALGS | Beigelman Leonid President | 50,781 | $0 | 214,623 (Indirect) | View |
| 2020-10-20 Conversion | 2020-10-20 4:53 pm | N/A N/A | Aligos Therapeutics Inc. | ALGS | Beigelman Leonid President | 3,359 | $0 | 16,918 (Indirect) | View |
| 2020-10-20 Conversion | 2020-10-20 4:53 pm | N/A N/A | Aligos Therapeutics Inc. | ALGS | Beigelman Leonid President | 3,359 | $0 | 16,918 (Indirect) | View |
| 2020-10-20 Conversion | 2020-10-20 4:53 pm | N/A N/A | Aligos Therapeutics Inc. | ALGS | Beigelman Leonid President | 21,724 | $0 | 236,347 (Indirect) | View |
| 2020-10-20 Conversion | 2020-10-20 4:53 pm | N/A N/A | Aligos Therapeutics Inc. | ALGS | Beigelman Leonid President | 1,437 | $0 | 18,355 (Indirect) | View |
| 2020-10-20 Conversion | 2020-10-20 4:53 pm | N/A N/A | Aligos Therapeutics Inc. | ALGS | Beigelman Leonid President | 1,437 | $0 | 18,355 (Indirect) | View |
| 2020-10-20 Conversion | 2020-10-20 4:53 pm | N/A N/A | Aligos Therapeutics Inc. | ALGS | Beigelman Leonid President | 163,842 | $0 | 0 (Indirect) | View |
| 2020-10-20 Conversion | 2020-10-20 4:53 pm | N/A N/A | Aligos Therapeutics Inc. | ALGS | Beigelman Leonid President | 13,559 | $0 | 0 (Indirect) | View |
| 2020-10-20 Conversion | 2020-10-20 4:53 pm | N/A N/A | Aligos Therapeutics Inc. | ALGS | Beigelman Leonid President | 13,559 | $0 | 0 (Indirect) | View |
| 2020-10-20 Conversion | 2020-10-20 4:53 pm | N/A N/A | Aligos Therapeutics Inc. | ALGS | Beigelman Leonid President | 50,781 | $0 | 0 (Indirect) | View |
| 2020-10-20 Conversion | 2020-10-20 4:53 pm | N/A N/A | Aligos Therapeutics Inc. | ALGS | Beigelman Leonid President | 3,359 | $0 | 0 (Indirect) | View |
| 2020-10-20 Conversion | 2020-10-20 4:53 pm | N/A N/A | Aligos Therapeutics Inc. | ALGS | Beigelman Leonid President | 3,359 | $0 | 0 (Indirect) | View |
| 2020-10-20 Conversion | 2020-10-20 4:53 pm | N/A N/A | Aligos Therapeutics Inc. | ALGS | Beigelman Leonid President | 21,724 | $0 | 0 (Indirect) | View |
| 2020-10-20 Conversion | 2020-10-20 4:53 pm | N/A N/A | Aligos Therapeutics Inc. | ALGS | Beigelman Leonid President | 1,437 | $0 | 0 (Indirect) | View |
| 2020-10-20 Conversion | 2020-10-20 4:53 pm | N/A N/A | Aligos Therapeutics Inc. | ALGS | Beigelman Leonid President | 1,437 | $0 | 0 (Indirect) | View |
| 2020-10-20 Conversion | 2020-10-20 4:55 pm | N/A N/A | Aligos Therapeutics Inc. | ALGS | BLATT LAWRENCE CEO | 41,016 | $0 | 41,016 (Indirect) | View |
| 2020-10-20 Conversion | 2020-10-20 4:55 pm | N/A N/A | Aligos Therapeutics Inc. | ALGS | BLATT LAWRENCE CEO | 122,601 | $0 | 122,601 (Indirect) | View |
| 2020-10-20 Conversion | 2020-10-20 4:55 pm | N/A N/A | Aligos Therapeutics Inc. | ALGS | BLATT LAWRENCE CEO | 13,671 | $0 | 13,671 (Indirect) | View |
| 2020-10-20 Conversion | 2020-10-20 4:55 pm | N/A N/A | Aligos Therapeutics Inc. | ALGS | BLATT LAWRENCE CEO | 13,671 | $0 | 13,671 (Indirect) | View |
| 2020-10-20 Conversion | 2020-10-20 4:55 pm | N/A N/A | Aligos Therapeutics Inc. | ALGS | BLATT LAWRENCE CEO | 50,712 | $0 | 91,728 (Indirect) | View |
| 2020-10-20 Conversion | 2020-10-20 4:55 pm | N/A N/A | Aligos Therapeutics Inc. | ALGS | BLATT LAWRENCE CEO | 3,394 | $0 | 17,065 (Indirect) | View |
| 2020-10-20 Conversion | 2020-10-20 4:55 pm | N/A N/A | Aligos Therapeutics Inc. | ALGS | BLATT LAWRENCE CEO | 3,394 | $0 | 17,065 (Indirect) | View |
| 2020-10-20 Conversion | 2020-10-20 4:55 pm | N/A N/A | Aligos Therapeutics Inc. | ALGS | BLATT LAWRENCE CEO | 21,695 | $0 | 113,423 (Indirect) | View |
| 2020-10-20 Conversion | 2020-10-20 4:55 pm | N/A N/A | Aligos Therapeutics Inc. | ALGS | BLATT LAWRENCE CEO | 1,452 | $0 | 18,517 (Indirect) | View |
| 2020-10-20 Conversion | 2020-10-20 4:55 pm | N/A N/A | Aligos Therapeutics Inc. | ALGS | BLATT LAWRENCE CEO | 1,452 | $0 | 18,517 (Indirect) | View |
| 2020-10-20 Conversion | 2020-10-20 4:55 pm | N/A N/A | Aligos Therapeutics Inc. | ALGS | BLATT LAWRENCE CEO | 41,016 | $0 | 0 (Indirect) | View |
| 2020-10-20 Conversion | 2020-10-20 4:55 pm | N/A N/A | Aligos Therapeutics Inc. | ALGS | BLATT LAWRENCE CEO | 122,601 | $0 | 0 (Indirect) | View |
| 2020-10-20 Conversion | 2020-10-20 4:55 pm | N/A N/A | Aligos Therapeutics Inc. | ALGS | BLATT LAWRENCE CEO | 13,671 | $0 | 0 (Indirect) | View |
| 2020-10-20 Conversion | 2020-10-20 4:55 pm | N/A N/A | Aligos Therapeutics Inc. | ALGS | BLATT LAWRENCE CEO | 13,671 | $0 | 0 (Indirect) | View |
| 2020-10-20 Conversion | 2020-10-20 4:55 pm | N/A N/A | Aligos Therapeutics Inc. | ALGS | BLATT LAWRENCE CEO | 50,712 | $0 | 0 (Indirect) | View |
| 2020-10-20 Conversion | 2020-10-20 4:55 pm | N/A N/A | Aligos Therapeutics Inc. | ALGS | BLATT LAWRENCE CEO | 3,394 | $0 | 0 (Indirect) | View |
| 2020-10-20 Conversion | 2020-10-20 4:55 pm | N/A N/A | Aligos Therapeutics Inc. | ALGS | BLATT LAWRENCE CEO | 3,394 | $0 | 0 (Indirect) | View |
| 2020-10-20 Conversion | 2020-10-20 4:55 pm | N/A N/A | Aligos Therapeutics Inc. | ALGS | BLATT LAWRENCE CEO | 21,695 | $0 | 0 (Indirect) | View |
| 2020-10-20 Conversion | 2020-10-20 4:55 pm | N/A N/A | Aligos Therapeutics Inc. | ALGS | BLATT LAWRENCE CEO | 1,452 | $0 | 0 (Indirect) | View |
| 2020-10-20 Conversion | 2020-10-20 4:55 pm | N/A N/A | Aligos Therapeutics Inc. | ALGS | BLATT LAWRENCE CEO | 1,452 | $0 | 0 (Indirect) | View |
| 2020-10-20 Conversion | 2020-10-20 4:55 pm | N/A N/A | Aligos Therapeutics Inc. | ALGS | Nuechterlein Carole Director | 2,145,991 | $0 | 2,145,991 (Indirect) | View |
| 2020-10-20 Conversion | 2020-10-20 4:55 pm | N/A N/A | Aligos Therapeutics Inc. | ALGS | Nuechterlein Carole Director | 662,799 | $0 | 2,808,790 (Indirect) | View |
| 2020-10-20 Conversion | 2020-10-20 4:55 pm | N/A N/A | Aligos Therapeutics Inc. | ALGS | Nuechterlein Carole Director | 283,550 | $0 | 3,092,340 (Indirect) | View |
| 2020-10-20 Conversion | 2020-10-20 4:55 pm | N/A N/A | Aligos Therapeutics Inc. | ALGS | Nuechterlein Carole Director | 2,145,991 | $0 | 0 (Indirect) | View |
| 2020-10-20 Conversion | 2020-10-20 4:55 pm | N/A N/A | Aligos Therapeutics Inc. | ALGS | Nuechterlein Carole Director | 662,799 | $0 | 0 (Indirect) | View |
| 2020-10-20 Conversion | 2020-10-20 4:55 pm | N/A N/A | Aligos Therapeutics Inc. | ALGS | Nuechterlein Carole Director | 283,550 | $0 | 0 (Indirect) | View |
| 2020-10-20 Conversion | 2020-10-20 4:56 pm | N/A N/A | Aligos Therapeutics Inc. | ALGS | Quan Lucinda Y. See Remarks | 6,835 | $0 | 6,835 (Indirect) | View |
| 2020-10-20 Conversion | 2020-10-20 4:56 pm | N/A N/A | Aligos Therapeutics Inc. | ALGS | Quan Lucinda Y. See Remarks | 1,697 | $0 | 8,532 (Indirect) | View |
| 2020-10-20 Conversion | 2020-10-20 4:56 pm | N/A N/A | Aligos Therapeutics Inc. | ALGS | Quan Lucinda Y. See Remarks | 726 | $0 | 9,258 (Indirect) | View |
| 2020-10-20 Conversion | 2020-10-20 4:56 pm | N/A N/A | Aligos Therapeutics Inc. | ALGS | Quan Lucinda Y. See Remarks | 6,835 | $0 | 0 (Indirect) | View |
| 2020-10-20 Conversion | 2020-10-20 4:56 pm | N/A N/A | Aligos Therapeutics Inc. | ALGS | Quan Lucinda Y. See Remarks | 1,697 | $0 | 0 (Indirect) | View |
| 2020-10-20 Conversion | 2020-10-20 4:56 pm | N/A N/A | Aligos Therapeutics Inc. | ALGS | Quan Lucinda Y. See Remarks | 726 | $0 | 0 (Indirect) | View |
| 2020-10-20 Conversion | 2020-10-20 4:57 pm | N/A N/A | Aligos Therapeutics Inc. | ALGS | Symons Julian A. See Remarks | 13,671 | $0 | 389,218 (Direct) | View |
| 2020-10-20 Conversion | 2020-10-20 4:57 pm | N/A N/A | Aligos Therapeutics Inc. | ALGS | Symons Julian A. See Remarks | 3,394 | $0 | 392,612 (Direct) | View |
| 2020-10-20 Conversion | 2020-10-20 4:57 pm | N/A N/A | Aligos Therapeutics Inc. | ALGS | Symons Julian A. See Remarks | 1,452 | $0 | 394,064 (Direct) | View |
| 2020-10-20 Conversion | 2020-10-20 4:57 pm | N/A N/A | Aligos Therapeutics Inc. | ALGS | Symons Julian A. See Remarks | 13,671 | $0 | 0 (Direct) | View |
| 2020-10-20 Conversion | 2020-10-20 4:57 pm | N/A N/A | Aligos Therapeutics Inc. | ALGS | Symons Julian A. See Remarks | 3,394 | $0 | 0 (Direct) | View |
| 2020-10-20 Conversion | 2020-10-20 4:57 pm | N/A N/A | Aligos Therapeutics Inc. | ALGS | Symons Julian A. See Remarks | 1,452 | $0 | 0 (Direct) | View |
| 2020-10-20 Conversion | 2020-10-20 4:58 pm | N/A N/A | Aligos Therapeutics Inc. | ALGS | Versant Venture Capital VI L.P. Versant Vantage I L.P. 10% Owner | 2,145,991 | $0 | 2,145,991 (Direct) | View |
| 2020-10-20 Conversion | 2020-10-20 4:58 pm | N/A N/A | Aligos Therapeutics Inc. | ALGS | Versant Venture Capital VI L.P. Versant Vantage I L.P. 10% Owner | 198,839 | $0 | 2,344,830 (Direct) | View |
| 2020-10-20 Conversion | 2020-10-20 4:58 pm | N/A N/A | Aligos Therapeutics Inc. | ALGS | Versant Venture Capital VI L.P. Versant Vantage I L.P. 10% Owner | 85,065 | $0 | 2,429,895 (Direct) | View |
| 2020-10-20 Conversion | 2020-10-20 4:58 pm | N/A N/A | Aligos Therapeutics Inc. | ALGS | Versant Venture Capital VI L.P. Versant Vantage I L.P. 10% Owner | 463,959 | $0 | 463,959 (Indirect) | View |
| 2020-10-20 Conversion | 2020-10-20 4:58 pm | N/A N/A | Aligos Therapeutics Inc. | ALGS | Versant Venture Capital VI L.P. Versant Vantage I L.P. 10% Owner | 198,485 | $0 | 662,444 (Indirect) | View |
| 2020-10-20 Conversion | 2020-10-20 4:58 pm | N/A N/A | Aligos Therapeutics Inc. | ALGS | Versant Venture Capital VI L.P. Versant Vantage I L.P. 10% Owner | 2,145,991 | $0 | 0 (Direct) | View |
| 2020-10-20 Conversion | 2020-10-20 4:58 pm | N/A N/A | Aligos Therapeutics Inc. | ALGS | Versant Venture Capital VI L.P. Versant Vantage I L.P. 10% Owner | 198,839 | $0 | 0 (Direct) | View |
| 2020-10-20 Conversion | 2020-10-20 4:58 pm | N/A N/A | Aligos Therapeutics Inc. | ALGS | Versant Venture Capital VI L.P. Versant Vantage I L.P. 10% Owner | 463,959 | $0 | 0 (Indirect) | View |
| 2020-10-20 Conversion | 2020-10-20 4:58 pm | N/A N/A | Aligos Therapeutics Inc. | ALGS | Versant Venture Capital VI L.P. Versant Vantage I L.P. 10% Owner | 85,065 | $0 | 0 (Direct) | View |
| 2020-10-20 Conversion | 2020-10-20 4:58 pm | N/A N/A | Aligos Therapeutics Inc. | ALGS | Versant Venture Capital VI L.P. Versant Vantage I L.P. 10% Owner | 198,485 | $0 | 0 (Indirect) | View |
| 2020-10-20 Conversion | 2020-10-20 4:59 pm | N/A N/A | Aligos Therapeutics Inc. | ALGS | Vivo Capital VIII LLC Vivo Capital Fund VIII L.P. Vivo Capital Surplus Fund VIII L.P. 10% Owner | 1,885,611 | $0 | 1,885,611 (Indirect) | View |
| 2020-10-20 Conversion | 2020-10-20 4:59 pm | N/A N/A | Aligos Therapeutics Inc. | ALGS | Vivo Capital VIII LLC Vivo Capital Fund VIII L.P. Vivo Capital Surplus Fund VIII L.P. 10% Owner | 523,726 | $0 | 2,409,337 (Indirect) | View |
| 2020-10-20 Conversion | 2020-10-20 4:59 pm | N/A N/A | Aligos Therapeutics Inc. | ALGS | Vivo Capital VIII LLC Vivo Capital Fund VIII L.P. Vivo Capital Surplus Fund VIII L.P. 10% Owner | 224,054 | $0 | 2,633,391 (Indirect) | View |
| 2020-10-20 Conversion | 2020-10-20 4:59 pm | N/A N/A | Aligos Therapeutics Inc. | ALGS | Vivo Capital VIII LLC Vivo Capital Fund VIII L.P. Vivo Capital Surplus Fund VIII L.P. 10% Owner | 260,380 | $0 | 260,380 (Indirect) | View |
| 2020-10-20 Conversion | 2020-10-20 4:59 pm | N/A N/A | Aligos Therapeutics Inc. | ALGS | Vivo Capital VIII LLC Vivo Capital Fund VIII L.P. Vivo Capital Surplus Fund VIII L.P. 10% Owner | 72,320 | $0 | 332,700 (Indirect) | View |
| 2020-10-20 Conversion | 2020-10-20 4:59 pm | N/A N/A | Aligos Therapeutics Inc. | ALGS | Vivo Capital VIII LLC Vivo Capital Fund VIII L.P. Vivo Capital Surplus Fund VIII L.P. 10% Owner | 30,939 | $0 | 363,639 (Indirect) | View |
| 2020-10-20 Conversion | 2020-10-20 4:59 pm | N/A N/A | Aligos Therapeutics Inc. | ALGS | Vivo Capital VIII LLC Vivo Capital Fund VIII L.P. Vivo Capital Surplus Fund VIII L.P. 10% Owner | 1,885,611 | $0 | 0 (Indirect) | View |
| 2020-10-20 Conversion | 2020-10-20 4:59 pm | N/A N/A | Aligos Therapeutics Inc. | ALGS | Vivo Capital VIII LLC Vivo Capital Fund VIII L.P. Vivo Capital Surplus Fund VIII L.P. 10% Owner | 260,380 | $0 | 0 (Indirect) | View |
| 2020-10-20 Conversion | 2020-10-20 4:59 pm | N/A N/A | Aligos Therapeutics Inc. | ALGS | Vivo Capital VIII LLC Vivo Capital Fund VIII L.P. Vivo Capital Surplus Fund VIII L.P. 10% Owner | 523,726 | $0 | 0 (Indirect) | View |
| 2020-10-20 Conversion | 2020-10-20 4:59 pm | N/A N/A | Aligos Therapeutics Inc. | ALGS | Vivo Capital VIII LLC Vivo Capital Fund VIII L.P. Vivo Capital Surplus Fund VIII L.P. 10% Owner | 72,320 | $0 | 0 (Indirect) | View |
| 2020-10-20 Conversion | 2020-10-20 4:59 pm | N/A N/A | Aligos Therapeutics Inc. | ALGS | Vivo Capital VIII LLC Vivo Capital Fund VIII L.P. Vivo Capital Surplus Fund VIII L.P. 10% Owner | 224,054 | $0 | 0 (Indirect) | View |
| 2020-10-20 Conversion | 2020-10-20 4:59 pm | N/A N/A | Aligos Therapeutics Inc. | ALGS | Vivo Capital VIII LLC Vivo Capital Fund VIII L.P. Vivo Capital Surplus Fund VIII L.P. 10% Owner | 30,939 | $0 | 0 (Indirect) | View |
| 2020-10-20 Conversion | 2020-10-20 5:00 pm | N/A N/A | Aligos Therapeutics Inc. | ALGS | Woiwode Thomas Director | 2,145,991 | $0 | 2,145,991 (Indirect) | View |
| 2020-10-20 Conversion | 2020-10-20 5:00 pm | N/A N/A | Aligos Therapeutics Inc. | ALGS | Woiwode Thomas Director | 198,839 | $0 | 2,344,830 (Indirect) | View |
| 2020-10-20 Conversion | 2020-10-20 5:00 pm | N/A N/A | Aligos Therapeutics Inc. | ALGS | Woiwode Thomas Director | 85,065 | $0 | 2,429,895 (Indirect) | View |
| 2020-10-20 Conversion | 2020-10-20 5:00 pm | N/A N/A | Aligos Therapeutics Inc. | ALGS | Woiwode Thomas Director | 463,959 | $0 | 463,959 (Indirect) | View |
| 2020-10-20 Conversion | 2020-10-20 5:00 pm | N/A N/A | Aligos Therapeutics Inc. | ALGS | Woiwode Thomas Director | 198,485 | $0 | 662,444 (Indirect) | View |
| 2020-10-20 Conversion | 2020-10-20 5:00 pm | N/A N/A | Aligos Therapeutics Inc. | ALGS | Woiwode Thomas Director | 2,145,991 | $0 | 0 (Indirect) | View |
| 2020-10-20 Conversion | 2020-10-20 5:00 pm | N/A N/A | Aligos Therapeutics Inc. | ALGS | Woiwode Thomas Director | 198,839 | $0 | 0 (Indirect) | View |
| 2020-10-20 Conversion | 2020-10-20 5:00 pm | N/A N/A | Aligos Therapeutics Inc. | ALGS | Woiwode Thomas Director | 463,959 | $0 | 0 (Indirect) | View |
| 2020-10-20 Conversion | 2020-10-20 5:00 pm | N/A N/A | Aligos Therapeutics Inc. | ALGS | Woiwode Thomas Director | 85,065 | $0 | 0 (Indirect) | View |
| 2020-10-20 Conversion | 2020-10-20 5:00 pm | N/A N/A | Aligos Therapeutics Inc. | ALGS | Woiwode Thomas Director | 198,485 | $0 | 0 (Indirect) | View |
| 2020-10-20 Conversion | 2020-10-22 4:12 pm | N/A N/A | Aligos Therapeutics Inc. | ALGS | Wellington Biomedical Innovation Master Investors (Cayman) I L.P. 10% Owner | 1,335,048 | $0 | 1,335,048 (Direct) | View |
| 2020-10-20 Conversion | 2020-10-22 4:12 pm | N/A N/A | Aligos Therapeutics Inc. | ALGS | Wellington Biomedical Innovation Master Investors (Cayman) I L.P. 10% Owner | 571,143 | $0 | 1,906,191 (Direct) | View |
| 2020-10-20 Conversion | 2020-10-22 4:12 pm | N/A N/A | Aligos Therapeutics Inc. | ALGS | Wellington Biomedical Innovation Master Investors (Cayman) I L.P. 10% Owner | 1,335,048 | $0 | 0 (Direct) | View |
| 2020-10-20 Conversion | 2020-10-22 4:12 pm | N/A N/A | Aligos Therapeutics Inc. | ALGS | Wellington Biomedical Innovation Master Investors (Cayman) I L.P. 10% Owner | 571,143 | $0 | 0 (Direct) | View |
| 2020-10-20 Conversion | 2020-10-22 4:31 pm | N/A N/A | Aligos Therapeutics Inc. | ALGS | Novo Holdings A/S 10% Owner | 2,414,563 | $0 | 2,414,563 (Direct) | View |
| 2020-10-20 Conversion | 2020-10-22 4:31 pm | N/A N/A | Aligos Therapeutics Inc. | ALGS | Novo Holdings A/S 10% Owner | 1,609,493 | $0 | 0 (Direct) | View |
| 2020-10-20 Conversion | 2020-10-22 4:31 pm | N/A N/A | Aligos Therapeutics Inc. | ALGS | Novo Holdings A/S 10% Owner | 563,851 | $0 | 0 (Direct) | View |
| 2020-10-20 Conversion | 2020-10-22 4:31 pm | N/A N/A | Aligos Therapeutics Inc. | ALGS | Novo Holdings A/S 10% Owner | 241,219 | $0 | 0 (Direct) | View |
| 2020-12-01 Option Award | 2020-12-03 8:03 pm | N/A 2030-12-01 | Aligos Therapeutics Inc. | ALGS | BLATT LAWRENCE CEO | 450,000 | $0 | 450,000 (Direct) | View |
| 2020-12-01 Option Award | 2020-12-03 8:03 pm | N/A 2030-12-01 | Aligos Therapeutics Inc. | ALGS | Beigelman Leonid President | 300,000 | $0 | 300,000 (Direct) | View |
| 2020-12-01 Option Award | 2020-12-03 8:04 pm | N/A 2030-12-01 | Aligos Therapeutics Inc. | ALGS | Quan Lucinda Y. See Remarks | 200,000 | $0 | 200,000 (Direct) | View |
| 2020-12-01 Option Award | 2020-12-03 8:04 pm | N/A 2030-12-01 | Aligos Therapeutics Inc. | ALGS | Calhoun Lesley Ann See Remarks | 176,237 | $0 | 176,237 (Direct) | View |
| 2020-12-01 Option Award | 2020-12-03 8:05 pm | N/A 2030-12-01 | Aligos Therapeutics Inc. | ALGS | Symons Julian A. See Remarks | 200,000 | $0 | 200,000 (Direct) | View |
| 2021-04-26 Option Award | 2021-04-27 4:42 pm | N/A 2031-04-26 | Aligos Therapeutics Inc. | ALGS | Scopa James Paul Director | 30,000 | $0 | 30,000 (Direct) | View |
| 2021-04-26 Other | 2021-04-28 5:00 pm | N/A N/A | Aligos Therapeutics Inc. | ALGS | Woiwode Thomas Director | 485,979 | $0 | 1,943,916 (Indirect) | View |
| 2021-04-26 Other | 2021-04-28 5:00 pm | N/A N/A | Aligos Therapeutics Inc. | ALGS | Woiwode Thomas Director | 9,720 | $0 | 9,720 (Indirect) | View |
| 2021-04-26 Other | 2021-04-28 5:00 pm | N/A N/A | Aligos Therapeutics Inc. | ALGS | Woiwode Thomas Director | 9,720 | $0 | 0 (Indirect) | View |
| 2021-04-26 Other | 2021-04-28 5:00 pm | N/A N/A | Aligos Therapeutics Inc. | ALGS | Woiwode Thomas Director | 8,385 | $0 | 8,385 (Indirect) | View |
| 2021-04-26 Other | 2021-04-28 5:00 pm | N/A N/A | Aligos Therapeutics Inc. | ALGS | Woiwode Thomas Director | 8,385 | $0 | 0 (Indirect) | View |
| 2021-04-26 Other | 2021-04-28 5:00 pm | N/A N/A | Aligos Therapeutics Inc. | ALGS | Woiwode Thomas Director | 2,226 | $0 | 2,226 (Direct) | View |